# Insulin medicines: Evolution

Source page: https://www.materialinsights.org/products/p_insulin_medicines/prod-evolution/

#### Timeline

The milestones of the product, each with a source

| Year | Event |
|---|---|
| 1923 | Eli Lilly begins selling Iletin, the first commercially available insulin product ^[3]^[4] |
| 1982 | The FDA approves Humulin, human insulin made by bacteria and the first FDA-approved recombinant drug of any kind ^[3] |
| 1996 | Humalog, the first rapid insulin analogue, is produced ^[5] |
| 2021 | WHO reports that three multinational companies control more than 90% of the insulin market; the UK PenCycle pen-return pilot starts in November ^[1]^[16] |
| 2022 | WHO prequalifies the first human insulins (Novo Nordisk), on 28 September ^[7] |
| 2026 | A once-weekly basal insulin, Awiqli, is on sale in India, and a press report says Novo Nordisk is withdrawing human insulin in Penfill cartridges and FlexPen devices there ^[10] |

as of 2026-11-13

#### Recipe changes

How what it is made of changed over time, and what drove each change

| Change | From | To | Driver | Source |
|---|---|---|---|---|
| What makes the insulin | Early insulins such as Iletin of 1923 ^[4]; pig insulin was later turned into human insulin with an enzyme ^[6] | Human insulin made by bacteria (Humulin, approved 1982) | The ACS booklet says bacteria make human insulin at 98% purity ^[3] | ^[3]^[4]^[6] |
| The molecule | Human insulin | Analogues, first the rapid analogue Humalog in 1996 | Faster action; the sources opened give no other reason | ^[5] |
| How often the dose is given | Once-daily basal insulin, 22 pens a patient a year (France, modelled) | Once-weekly basal insulin, 5 pens a patient a year (France, modelled) | Fewer injections and pens ^[14] | ^[14] |

as of 2026-11-13

#### What could improve it next

Directions for improvement, today's value and the limit

| Direction | Metric | Today | Unit | Source |
|---|---|---|---|---|
| Once-weekly basal insulin | Pens used per patient in a year | 5 | pens per year (22 for once-daily; no limit stated) | ^[14] |
| Insulin that tolerates warmth | Weeks allowed at up to 30 degrees C before opening (human insulin, Novo Nordisk) | 4 | weeks (no limit stated) | ^[7] |
| Reach people who need insulin but do not get it | Share of people with type 2 diabetes needing insulin who do not get it | 50 | % (one in two, calculated; no limit stated) | ^[1] |

as of 2026-11-13

#### Sources

1. [New WHO report maps barriers to insulin availability and suggests actions to promote universal access](https://www.who.int/news/item/12-11-2021-new-who-report-maps-barriers-to-insulin-availability-and-suggests-actions-to-promote-universal-access) World Health Organization, 2021, news item of 12 November 2021
2. [Insulin Development and Commercialization](https://www.Acs.Org/content/dam/acsorg/education/whatischemistry/landmarks/insulin/insulin-booklet.pdf) American Chemical Society (National Historic Chemical Landmark), 2023, landmark booklet, © 2023 American Chemical Society
3. [Manufactured insulin, 'Iletin', United States, 1923 | Science Museum Group Collection](https://collection.sciencemuseumgroup.org.uk/objects/co143500/manufactured-insulin-iletin-united-states-1923-insulin) Science Museum Group, object record co143500
4. [100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the Future](https://pmc.ncbi.nlm.nih.gov/articles/PMC10968222) Biomedicines (MDPI), on PubMed Central, 2024
5. [Insulin: Recombinant Production, Sustainability, and Chemistry](https://oxfordglobal.com/biologics/resources/insulin-recombinant-production-sustainability-and-chemistry) Oxford Global (article by Tom Cohen on a presentation by Thomas Høeg-Jensen, Scientific Director at Novo Nordisk), 2023, page of 25 April 2023
6. [First human insulins prequalified](https://extranet.who.int/pqweb/news/first-human-insulins-prequalified) World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
7. [India 2030: Who Supplies the Next 10 Million?](https://www.biospectrumindia.com/features/18/28731/india-2030-who-supplies-the-next-10-million.html) BioSpectrum India (Ankit Kankar), 2026, article of 1 November 2026
8. [Environmental Impact of Switching from Daily to Weekly Basal Insulin Administration in France](https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4014/145501) ISPOR Europe 2024 abstract EE212 (Bellier L, Antier C, Soggiu M, Virely N, Laporte L, Sivignon M, Kind B; affiliations Putnam, Paris, and Novo Nordisk, Paris), Value in Health 27(12) S2, 2024
9. [Patients return 200,000 injection pens through recycling scheme](https://pharmaceutical-journal.com/article/news/patients-return-200000-injection-pens-through-recycling-scheme) The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023

## Other sections

- [Summary](https://www.materialinsights.org/products/p_insulin_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_insulin_medicines/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_insulin_medicines/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_insulin_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_insulin_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_insulin_medicines/prod-footprint/index.md)
- [Interventions](https://www.materialinsights.org/products/p_insulin_medicines/prod-interventions/index.md)
